Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Publication summary
Topics
Publications
Real-world evidence
Methodology
Health equity
Non-small cell lung cancer
Machine learning
Clinical research
Multiple myeloma
HTA and market access
Metastatic breast cancer
Breast cancer
Regulatory
Clinical decision support
Point of care
Advanced endometrial cancer
Colorectal cancer
Prospective study
Comparative effectiveness
Treatment patterns
EHR-to-EDC
Urothelial cell carcinoma
Data science
Ovarian cancer
AP - Blythe Adamson, MPH, PhD
Acute myeloid leukemia
Small cell lung cancer
Precision medicine
Prostate cancer
Diffuse large B-Cell lymphoma
Trial design
AP - Ivy Altomare, MD
Post marketing requirements
Research
Melanoma
Practice management
Content type
Publication summary
Press releases
Video
Case study
Clear
Apply filter
Showing 9 of
0
results
Using regression discontinuity in time design for real-world comparative effectiveness: A case study for the second-line use of pembrolizumab in advanced non-small cell lung cancer
ISPOR 2025
Publication summary
Publications
Comparative effectiveness
Non-small cell lung cancer
Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
Blood Cancer Journal
Publication summary
Publications
Clinical decision support
Treatment patterns
Multiple myeloma
From data to decisions: the role of real-world evidence in recent multiple myeloma drug approvals in the US and EU
ISPOR
Real-world evidence
Publication summary
Publications
Regulatory
Leveraging machine learning to assess the association of rash and survival in patients with advanced NSCLC
ISPOR
Real-world evidence
Publication summary
Publications
Machine learning
Performance assessment and validation of real-world response data generated using a deep learning-based natural language processing model across multiple solid tumors
ISPOR
Real-world evidence
Publication summary
Publications
Machine learning
Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLC
ISPOR
Real-world evidence
Publication summary
Publications
Methodology
Non-small cell lung cancer
Augmenting race and ethnicity in a real-world oncology cohort using the Bayesian improved surname geocoding methodology
ISPOR
Real-world evidence
Publication summary
Publications
Advancing breast cancer research in Japan using EHR-derived real-world data
ISPOR
Real-world evidence
Publication summary
Publications
Machine learning
Patient characteristics and treatment patterns in extensive-stage small cell lung cancer (ES-SCLC)
ISPOR
Publication summary
Publications
Machine learning
Small cell lung cancer
View more